We estimate that the President and CEO of NEW YORK TIMES CO ($NYT), Meredith Kopit Levien, received a compensation of $8,862,362 in 2025. This is an increase of 11.74% from an estimated $7,821,993 in 2024.
These estimates are based on a new DEF14A filing, filed with the SEC on March 13, 2026. Note that parsing errors may occur.
You can track $NYT on Quiver Quantitative's $NYT stock dashboard.
$NYT Stock Insider Trading Activity
$NYT Stock insiders have traded $NYT stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $NYT stock by insiders over the last 6 months:
- LEVIEN MEREDITH A. KOPIT (PRESIDENT & CEO) has made 0 purchases and 2 sales selling 68,921 shares for an estimated $5,153,379.
- WILLIAM BARDEEN (EVP, Chief Financial Officer) sold 13,000 shares for an estimated $1,034,280
- DIANE BRAYTON (EVP, CHIEF LEGAL OFFICER) sold 4,600 shares for an estimated $354,338
- R ANTHONY BENTEN (SVP, Treasurer & CAO) sold 1,913 shares for an estimated $140,747
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$NYT Stock Government Contracts
We have seen $53,087 of award payments to $NYT over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- NY TIMES.COM ACCESS, ENTERPRISE ACCESS SUBSCRIPTION: $40,487
- THE REQUIREMENT IS TO PROVIDE ACCESS TO NEW YORK TIMES ONLINE FOR 105 SEATS AT A TOTAL COST OF $12,600.00 F...: $12,600
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
$NYT Stock Hedge Fund Activity
We have seen 282 institutional investors add shares of $NYT Stock stock to their portfolio, and 288 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BERKSHIRE HATHAWAY INC added 5,065,744 shares (+inf%) to their portfolio in Q4 2025, for an estimated $351,663,948
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 4,339,689 shares (-40.5%) from their portfolio in Q4 2025, for an estimated $301,261,210
- BANK OF MONTREAL /CAN/ added 2,293,281 shares (+10018.3%) to their portfolio in Q4 2025, for an estimated $159,199,567
- FARALLON CAPITAL MANAGEMENT LLC removed 1,705,067 shares (-34.2%) from their portfolio in Q4 2025, for an estimated $118,365,751
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 1,673,370 shares (-76.9%) from their portfolio in Q4 2025, for an estimated $116,165,345
- AQR CAPITAL MANAGEMENT LLC added 1,628,200 shares (+35.3%) to their portfolio in Q4 2025, for an estimated $113,029,644
- EGERTON CAPITAL (UK) LLP added 1,410,003 shares (+inf%) to their portfolio in Q4 2025, for an estimated $97,882,408
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$NYT Stock Analyst Ratings
Wall Street analysts have issued reports on $NYT in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Citigroup issued a "Buy" rating on 12/23/2025
- JP Morgan issued a "Overweight" rating on 11/06/2025
To track analyst ratings and price targets for $NYT Stock, check out Quiver Quantitative's $NYT forecast page.
$NYT Stock Price Targets
Multiple analysts have issued price targets for $NYT recently. We have seen 5 analysts offer price targets for $NYT in the last 6 months, with a median target of $74.0.
Here are some recent targets:
- David Karnovsky from JP Morgan set a target price of $74.0 on 02/05/2026
- Jason Bazinet from Citigroup set a target price of $77.0 on 02/05/2026
- Vijay Jayant from Evercore ISI Group set a target price of $75.0 on 02/05/2026
- Kannan Venkateshwar from Barclays set a target price of $60.0 on 01/20/2026
- Thomas Yeh from Morgan Stanley set a target price of $62.0 on 11/06/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.